BACKGROUND: Dibenzoazepine (DB) derivatives are important and valuable compounds in medicinal chemistry. The synthesis and chemotherapeutic properties of naturally occurring DBs and different heterocyclic moiety tethered DBs are reported. Herein, we report the DB-fused hybrid structure that containing isoxazolines (DBIs) and their anti-cancer activity, which could throw light on the structural and functional features of new molecules. RESULTS AND CONCLUSION: The synthesis and characterization of novel ring DB tethered isoxazoline derivatives (DBIs) were carried out. After the detailed structural characterization using 2D-NMR experiments, the compounds were identified as 5-substituted isoxazolines. The effect of newly synthesized DBIs against the invasion of murine osteosarcoma (LM8G7) cells was studied. Among the tested molecules, compound 4g (5-[-3-(4-chlorophenyl)-4,5-dihydroisoxazol-5-yl-methyl]-5 H-dibenzo[b,f]azepine), was found to inhibit the invasion of LM8G7 cells strongly, when compared to other structurally related compounds. Cumulatively, the compound 4g inhibited the invasion MDA-MB-231 cells completely at 10 μM. In addition to anti-invasion property the compound 4g also inhibited the migration of LM8G7 and human ovarian cancer cells (OVSAHO) dose-dependently. Compound 4g inhibited the proliferation of LM8G7, OVSAHO, human breast cancer cells (MCF-7) and human melphalan-resistant multiple myeloma (RPMI8226-LR5) cells that are comparable to cisplatin and suramin.
BACKGROUND:Dibenzoazepine (DB) derivatives are important and valuable compounds in medicinal chemistry. The synthesis and chemotherapeutic properties of naturally occurring DBs and different heterocyclic moiety tetheredDBsare reported. Herein, we report the DB-fused hybrid structure that containing isoxazolines (DBIs) and their anti-cancer activity, which could throw light on the structural and functional features of new molecules. RESULTS AND CONCLUSION: The synthesis and characterization of novel ring DB tethered isoxazoline derivatives (DBIs) were carried out. After the detailed structural characterization using 2D-NMR experiments, the compounds were identified as 5-substituted isoxazolines. The effect of newly synthesized DBIs against the invasion of murineosteosarcoma (LM8G7) cells was studied. Among the tested molecules, compound 4g (5-[-3-(4-chlorophenyl)-4,5-dihydroisoxazol-5-yl-methyl]-5 H-dibenzo[b,f]azepine), was found to inhibit the invasion of LM8G7cells strongly, when compared to other structurally related compounds. Cumulatively, the compound 4g inhibited the invasion MDA-MB-231cells completely at 10 μM. In addition to anti-invasion property the compound 4g also inhibited the migration of LM8G7 and humanovarian cancercells (OVSAHO) dose-dependently. Compound 4g inhibited the proliferation of LM8G7, OVSAHO, humanbreast cancercells (MCF-7) and human melphalan-resistant multiple myeloma (RPMI8226-LR5) cells that are comparable to cisplatin and suramin.
Authors: Ahmed Kamal; S Prabhakar; M Janaki Ramaiah; P Venkat Reddy; Ch Ratna Reddy; A Mallareddy; Nagula Shankaraiah; T Lakshmi Narayan Reddy; S N C V L Pushpavalli; Manika Pal-Bhadra Journal: Eur J Med Chem Date: 2011-05-30 Impact factor: 6.514
Authors: B S Priya; S Nanjunda Swamy; M V Tejesvi; G Sarala; S L Gaonkar; S Naveen; J Shashidhara Prasad; K S Rangappa Journal: Eur J Med Chem Date: 2006-07-05 Impact factor: 6.514
Authors: Ahmed Kamal; Y V V Srikanth; M Janaki Ramaiah; M Naseer Ahmed Khan; M Kashi Reddy; Md Ashraf; A Lavanya; S N C V L Pushpavalli; Manika Pal-Bhadra Journal: Bioorg Med Chem Lett Date: 2011-10-31 Impact factor: 2.823
Authors: Auriekson N Queiroz; Camila C Martins; Kelton L B Santos; Ederson S Carvalho; Alex O Owiti; Karen R M Oliveira; Anderson M Herculano; Albérico B F da Silva; Rosivaldo S Borges Journal: Saudi Pharm J Date: 2020-06-12 Impact factor: 4.330
Authors: Chakrabhavi Dhananjaya Mohan; V Srinivasa; Shobith Rangappa; Lewis Mervin; Surender Mohan; Shardul Paricharak; Sefer Baday; Feng Li; Muthu K Shanmugam; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Andreas Bender; Gautam Sethi; Kanchugarakoppal S Rangappa Journal: PLoS One Date: 2016-04-20 Impact factor: 3.240